JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations, 2015
Appointment of Mr. Manish Gupta as the Managing Director of the company. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Change in Directorate
Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Infinity Holdings & PACs JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aresko Progressive Pvt Ltd JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations, 2015
Share purchase agreement dated 21 February 2022 has been entered into amongst the existing promoters of the Company (being Aresko Progressive Private Limited (acting in capacity as a trustee of the Aresko Progressive Trust and as the representative partner of J&P Investments Partnership) ('Seller') and Mr. Rajpal Singh Kochhar) and Infinity Holdings, Infinity Holdings Sidecar I and Infinity Consumer Holdings ('Purchasers') ('SPA') for the transfer of up to 1,14,55,500 (One Crore Fourteen Lakhs Fifty Five Thousand Five Hundred) equity shares representing approximately 43.73% of the issued and paid-up equity share capital of the Company held by the Seller to the Purchasers at a price of INR 235 (Indian Rupees Two Hundred and Thirty Five only) per equity share in the manner and subject to the terms, conditions, and provisions set forth in the SPA JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Pre-Offer Advertisement
Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, for the attention of the public shareholders of Jagsonpal Pharmaceuticals Ltd ("Target Company"). JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Jagsonpal Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Outcome Of The Extra-Ordinary General Meeting
Proceeding of the Extra-Ordinary General Meeting held on 17th June, 2022. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Disclosure Of Related Party Transactions On Consolidated Basis For The Half Year Ended 31 March, 2022
Please find enclosed herewith disclosures of related party transactions on consolidated basis, as prescribed under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22nd November 2021, for the half year ended 31st March, 2022.